Evidence map›Paper›PMID 29228133›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Regional Epidemiology of Methicillin-Resistant Staphylococcus aureus Among Adult Intensive Care Unit Patients Following State-Mandated Active Surveillance.

Michael Y Lin, Mary K Hayden, Rosie D Lyles, Karen Lolans, Louis F Fogg, Alexander J Kallen, Stephen G Weber, Robert A Weinstein, William E Trick, Prevention Epicenters Program, Centers for Disease Control and Prevention

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Risk Factors for Methicillin-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  4. IDCases · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michael Y LinRush University Medical Center, Chicago, Illinois.
Mary K HaydenRush University Medical Center, Chicago, Illinois.
Rosie D LylesCook County Health and Hospitals System, Chicago, Illinois.
Karen LolansRush University Medical Center, Chicago, Illinois.
Louis F FoggRush University Medical Center, Chicago, Illinois.
Alexander J KallenCenters for Disease Control and Prevention, Atlanta, Georgia.
Stephen G WeberUniversity of Chicago Medicine, Illinois.
Robert A WeinsteinRush University Medical Center, Chicago, Illinois.
William E TrickRush University Medical Center, Chicago, Illinois.
Prevention Epicenters Program, Centers for Disease Control and Prevention

Funding

Chicago Antimicrobial Resistance and Infection Prevention Epi-Center (CARPE)U01CI000327 · CI · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI WEINSTEIN, ROBERT A. · 2006 to 2010
$2.5M
Intramural CDC HHS CC999999NCEZID CDC HHS U54 CK000161NCEZID CDC HHS U54 CK000481NCPDCID CDC HHS U01 CI000327
6 · The paper itself

Abstract

Background: In 2007, Illinois became the first state in the United States to mandate active surveillance of methicillin-resistant Staphylococcus aureus (MRSA). The Illinois law applies to intensive care unit (ICU) patients; contact precautions are required for patients found to be MRSA colonized. However, the effectiveness of a legislated "search and isolate" approach to reduce MRSA burden among critically ill patients is uncertain. We evaluated whether the prevalence of MRSA colonization declined in the 5 years after the start of mandatory active surveillance. Methods: All hospitals with an ICU having ≥10 beds in Chicago, Illinois, were eligible to participate in single-day serial point prevalence surveys. We assessed MRSA colonization among adult ICU patients present at time of survey using nasal and inguinal swab cultures. The primary outcome was region-wide MRSA colonization prevalence over time. Results: All 25 eligible hospitals (51 ICUs) participated in serial point prevalence surveys over 8 survey periods (2008-2013). A total of 3909 adult ICU patients participated in the point prevalence surveys, with 432 (11.1%) found to be colonized with MRSA (95% confidence interval [CI], 10.1%-12.0%). The MRSA colonization prevalence among patients was unchanged during the study period; year-over-year relative risk for MRSA colonization was 0.97 (95% CI, .89-1.05; P = .48). Conclusions: MRSA colonization prevalence among critically ill adult patients did not decline during the time period following legislatively mandated MRSA active surveillance. Our findings highlight the limits of legislated MRSA active surveillance as a strategy to reduce MRSA colonization burden among ICU patients.

Indexed as

Disease NotificationIntensive Care UnitsPopulation SurveillanceAgedCarrier StateCritical IllnessFemaleHumansIllinoisMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedPrevalenceStaphylococcal Infections

Identifiers

PMID29228133
PMCPMC6484427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.